

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 7.71194526 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 7.36374992 |
| 3 | negative regulation of cell killing (GO:0031342) | 7.36374992 |
| 4 | leukocyte aggregation (GO:0070486) | 5.66743330 |
| 5 | activated T cell proliferation (GO:0050798) | 5.40809870 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.32460902 |
| 7 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.26795954 |
| 8 | T cell migration (GO:0072678) | 5.14283843 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 5.04411975 |
| 10 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.77055943 |
| 11 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.75953497 |
| 12 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.75953497 |
| 13 | cellular response to interleukin-15 (GO:0071350) | 4.71221460 |
| 14 | negative regulation of phagocytosis (GO:0050765) | 4.66383278 |
| 15 | negative regulation of stress fiber assembly (GO:0051497) | 4.38436385 |
| 16 | response to interleukin-15 (GO:0070672) | 4.31810801 |
| 17 | macrophage activation involved in immune response (GO:0002281) | 4.18226408 |
| 18 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.14057274 |
| 19 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.12410920 |
| 20 | lymphocyte migration (GO:0072676) | 4.10252181 |
| 21 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.04578326 |
| 22 | negative T cell selection (GO:0043383) | 4.00642774 |
| 23 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.96002257 |
| 24 | regulation of T cell tolerance induction (GO:0002664) | 3.95773320 |
| 25 | neutrophil activation (GO:0042119) | 3.95200195 |
| 26 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.93962034 |
| 27 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.93631144 |
| 28 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.89388199 |
| 29 | regulation of gamma-delta T cell activation (GO:0046643) | 3.86437506 |
| 30 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.85413022 |
| 31 | cytidine deamination (GO:0009972) | 3.82711945 |
| 32 | cytidine metabolic process (GO:0046087) | 3.82711945 |
| 33 | cytidine catabolic process (GO:0006216) | 3.82711945 |
| 34 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.81793589 |
| 35 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.81793589 |
| 36 | modulation by symbiont of host immune response (GO:0052553) | 3.81793589 |
| 37 | positive regulation by symbiont of host defense response (GO:0052509) | 3.81793589 |
| 38 | modulation by symbiont of host defense response (GO:0052031) | 3.81793589 |
| 39 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.81793589 |
| 40 | positive thymic T cell selection (GO:0045059) | 3.81475907 |
| 41 | negative thymic T cell selection (GO:0045060) | 3.74899373 |
| 42 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.71322059 |
| 43 | detection of bacterium (GO:0016045) | 3.67471934 |
| 44 | regulation of regulatory T cell differentiation (GO:0045589) | 3.64265888 |
| 45 | cytolysis (GO:0019835) | 3.63583091 |
| 46 | detection of other organism (GO:0098543) | 3.63030128 |
| 47 | interferon-gamma production (GO:0032609) | 3.61660605 |
| 48 | positive T cell selection (GO:0043368) | 3.61034190 |
| 49 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.52503724 |
| 50 | respiratory burst (GO:0045730) | 3.51930648 |
| 51 | granulocyte activation (GO:0036230) | 3.50563247 |
| 52 | positive regulation of cell killing (GO:0031343) | 3.50177878 |
| 53 | regulation of tolerance induction (GO:0002643) | 3.48600375 |
| 54 | type I interferon signaling pathway (GO:0060337) | 3.47953717 |
| 55 | cellular response to type I interferon (GO:0071357) | 3.47953717 |
| 56 | regulation of B cell differentiation (GO:0045577) | 3.46580082 |
| 57 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.46128827 |
| 58 | response to type I interferon (GO:0034340) | 3.45006364 |
| 59 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.43736259 |
| 60 | cellular defense response (GO:0006968) | 3.43509073 |
| 61 | regulation of cell killing (GO:0031341) | 3.40403236 |
| 62 | maturation of SSU-rRNA (GO:0030490) | 3.38109831 |
| 63 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.34102296 |
| 64 | T cell receptor signaling pathway (GO:0050852) | 3.31325228 |
| 65 | myeloid cell activation involved in immune response (GO:0002275) | 3.28454102 |
| 66 | T cell selection (GO:0045058) | 3.24978938 |
| 67 | thymic T cell selection (GO:0045061) | 3.24450044 |
| 68 | immunoglobulin mediated immune response (GO:0016064) | 3.24275800 |
| 69 | lymphocyte chemotaxis (GO:0048247) | 3.23780853 |
| 70 | microglial cell activation (GO:0001774) | 3.21647771 |
| 71 | cellular extravasation (GO:0045123) | 3.17575106 |
| 72 | positive regulation of tolerance induction (GO:0002645) | 3.17152951 |
| 73 | negative regulation of actin filament bundle assembly (GO:0032232) | 3.16024937 |
| 74 | positive regulation of mast cell activation (GO:0033005) | 3.15239210 |
| 75 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.14585256 |
| 76 | mast cell activation (GO:0045576) | 3.11717723 |
| 77 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.10899721 |
| 78 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.10831244 |
| 79 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.08806585 |
| 80 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.08646823 |
| 81 | heart trabecula morphogenesis (GO:0061384) | 3.02307036 |
| 82 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.99800064 |
| 83 | positive regulation of interleukin-17 production (GO:0032740) | 2.99490838 |
| 84 | positive regulation of isotype switching (GO:0045830) | 2.98090149 |
| 85 | NIK/NF-kappaB signaling (GO:0038061) | 2.97476111 |
| 86 | DNA deamination (GO:0045006) | 2.95760038 |
| 87 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 2.95706719 |
| 88 | regulation of activation of Janus kinase activity (GO:0010533) | 2.93239389 |
| 89 | negative regulation of T cell mediated immunity (GO:0002710) | 2.92880834 |
| 90 | macrophage chemotaxis (GO:0048246) | 2.91671385 |
| 91 | positive regulation of B cell differentiation (GO:0045579) | 2.91312153 |
| 92 | positive regulation of B cell mediated immunity (GO:0002714) | 2.90920725 |
| 93 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.90920725 |
| 94 | leukocyte cell-cell adhesion (GO:0007159) | 2.90436429 |
| 95 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.89900435 |
| 96 | trabecula morphogenesis (GO:0061383) | 2.87699749 |
| 97 | negative regulation of innate immune response (GO:0045824) | 2.85703483 |
| 98 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 11.7792905 |
| 99 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 11.3778712 |
| 100 | antigen processing and presentation of endogenous antigen (GO:0019883) | 10.3549435 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.39442237 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.21214273 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.55761478 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.33284104 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.90609268 |
| 6 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.68899929 |
| 7 | MYB_26560356_Chip-Seq_TH2_Human | 2.85738519 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.80292601 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.77882686 |
| 10 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.72577451 |
| 11 | UTX_26944678_Chip-Seq_JUKART_Human | 2.70719142 |
| 12 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.66924070 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.65358453 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.61788713 |
| 15 | MAF_26560356_Chip-Seq_TH1_Human | 2.54664224 |
| 16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.45786606 |
| 17 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.43915449 |
| 18 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.36092685 |
| 19 | MYB_26560356_Chip-Seq_TH1_Human | 2.34421259 |
| 20 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.25444662 |
| 21 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.20261373 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.16875648 |
| 23 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.10682716 |
| 24 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.09158805 |
| 25 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.08436637 |
| 26 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.06543920 |
| 27 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.94827707 |
| 28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.94788114 |
| 29 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.92751751 |
| 30 | SPI1_23127762_ChIP-Seq_K562_Human | 1.91325041 |
| 31 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85564548 |
| 32 | MAF_26560356_Chip-Seq_TH2_Human | 1.83670267 |
| 33 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80675193 |
| 34 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.80232654 |
| 35 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.78087251 |
| 36 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.76069664 |
| 37 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.73081403 |
| 38 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.70192746 |
| 39 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.67307378 |
| 40 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.66744268 |
| 41 | GATA3_26560356_Chip-Seq_TH2_Human | 1.65678645 |
| 42 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61688303 |
| 43 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.61472125 |
| 44 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.53573841 |
| 45 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.48390226 |
| 46 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.47462750 |
| 47 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.43882335 |
| 48 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.37577508 |
| 49 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.33582073 |
| 50 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.33314656 |
| 51 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.33189993 |
| 52 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.32511801 |
| 53 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.30484003 |
| 54 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.27577886 |
| 55 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.27061789 |
| 56 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24342709 |
| 57 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.23697151 |
| 58 | MYC_22102868_ChIP-Seq_BL_Human | 1.21216432 |
| 59 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.19618061 |
| 60 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15352412 |
| 61 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.13417363 |
| 62 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.13234170 |
| 63 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.13051748 |
| 64 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.11386961 |
| 65 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.10210046 |
| 66 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.09494064 |
| 67 | SA1_27219007_Chip-Seq_Bcells_Human | 1.08528051 |
| 68 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.05834064 |
| 69 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03923422 |
| 70 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03765838 |
| 71 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.02642369 |
| 72 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.02388172 |
| 73 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.01840354 |
| 74 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.95794881 |
| 75 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.95565275 |
| 76 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.95248009 |
| 77 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94770645 |
| 78 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94237214 |
| 79 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.94132038 |
| 80 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.92772178 |
| 81 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.92216904 |
| 82 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.91799305 |
| 83 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90414440 |
| 84 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.90030376 |
| 85 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.89980298 |
| 86 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.89904891 |
| 87 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.89468667 |
| 88 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89150992 |
| 89 | GATA1_19941826_ChIP-Seq_K562_Human | 0.88374671 |
| 90 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87725449 |
| 91 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.87667618 |
| 92 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85315530 |
| 93 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.82828617 |
| 94 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.81654200 |
| 95 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.81417739 |
| 96 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.79341869 |
| 97 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78237674 |
| 98 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.77843180 |
| 99 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77733592 |
| 100 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.77464503 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.33405470 |
| 2 | MP0005671_abnormal_response_to | 5.14715686 |
| 3 | MP0006082_CNS_inflammation | 4.99930904 |
| 4 | MP0003724_increased_susceptibility_to | 3.59095410 |
| 5 | MP0003436_decreased_susceptibility_to | 3.33391926 |
| 6 | MP0001800_abnormal_humoral_immune | 3.23676066 |
| 7 | MP0005025_abnormal_response_to | 3.13841627 |
| 8 | MP0009785_altered_susceptibility_to | 3.13216354 |
| 9 | MP0005000_abnormal_immune_tolerance | 3.03666053 |
| 10 | MP0003763_abnormal_thymus_physiology | 2.98520545 |
| 11 | MP0002419_abnormal_innate_immunity | 2.86328246 |
| 12 | MP0002420_abnormal_adaptive_immunity | 2.83563552 |
| 13 | MP0005387_immune_system_phenotype | 2.79881479 |
| 14 | MP0001790_abnormal_immune_system | 2.79881479 |
| 15 | MP0002723_abnormal_immune_serum | 2.77914026 |
| 16 | MP0001819_abnormal_immune_cell | 2.77011055 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.68156555 |
| 18 | MP0009333_abnormal_splenocyte_physiolog | 2.56987948 |
| 19 | MP0000685_abnormal_immune_system | 2.39506098 |
| 20 | MP0002132_abnormal_respiratory_system | 2.22874471 |
| 21 | MP0010155_abnormal_intestine_physiology | 2.15337460 |
| 22 | MP0002405_respiratory_system_inflammati | 2.11535329 |
| 23 | MP0000716_abnormal_immune_system | 2.09598180 |
| 24 | MP0002398_abnormal_bone_marrow | 2.05970163 |
| 25 | MP0000858_altered_metastatic_potential | 2.05891500 |
| 26 | MP0001873_stomach_inflammation | 1.98542400 |
| 27 | MP0003300_gastrointestinal_ulcer | 1.92783733 |
| 28 | MP0002148_abnormal_hypersensitivity_rea | 1.81376891 |
| 29 | MP0005464_abnormal_platelet_physiology | 1.79453924 |
| 30 | MP0002138_abnormal_hepatobiliary_system | 1.77803331 |
| 31 | MP0001845_abnormal_inflammatory_respons | 1.74590903 |
| 32 | MP0002933_joint_inflammation | 1.72459912 |
| 33 | MP0002722_abnormal_immune_system | 1.72189956 |
| 34 | MP0003690_abnormal_glial_cell | 1.68743774 |
| 35 | MP0000689_abnormal_spleen_morphology | 1.67251450 |
| 36 | MP0001851_eye_inflammation | 1.62645403 |
| 37 | MP0000703_abnormal_thymus_morphology | 1.61697536 |
| 38 | MP0003866_abnormal_defecation | 1.61425302 |
| 39 | MP0001533_abnormal_skeleton_physiology | 1.60923450 |
| 40 | MP0002429_abnormal_blood_cell | 1.58222864 |
| 41 | MP0003448_altered_tumor_morphology | 1.58162485 |
| 42 | MP0003303_peritoneal_inflammation | 1.53837880 |
| 43 | MP0001348_abnormal_lacrimal_gland | 1.46784590 |
| 44 | MP0008469_abnormal_protein_level | 1.45669614 |
| 45 | MP0004947_skin_inflammation | 1.45020394 |
| 46 | MP0002277_abnormal_respiratory_mucosa | 1.34571724 |
| 47 | MP0005310_abnormal_salivary_gland | 1.34219605 |
| 48 | MP0002998_abnormal_bone_remodeling | 1.32511994 |
| 49 | MP0001986_abnormal_taste_sensitivity | 1.28238405 |
| 50 | MP0005166_decreased_susceptibility_to | 1.26557684 |
| 51 | MP0006054_spinal_hemorrhage | 1.25128069 |
| 52 | MP0002166_altered_tumor_susceptibility | 1.23410357 |
| 53 | MP0004510_myositis | 1.16279791 |
| 54 | MP0004381_abnormal_hair_follicle | 1.13351755 |
| 55 | MP0003195_calcinosis | 1.09731051 |
| 56 | MP0009763_increased_sensitivity_to | 1.05113394 |
| 57 | MP0001663_abnormal_digestive_system | 1.04014388 |
| 58 | MP0004883_abnormal_blood_vessel | 1.02018501 |
| 59 | MP0000490_abnormal_crypts_of | 0.99483078 |
| 60 | MP0003646_muscle_fatigue | 0.97143022 |
| 61 | MP0005164_abnormal_response_to | 0.94603750 |
| 62 | MP0009764_decreased_sensitivity_to | 0.92627976 |
| 63 | MP0008260_abnormal_autophagy | 0.92175292 |
| 64 | MP0000465_gastrointestinal_hemorrhage | 0.88047283 |
| 65 | MP0001529_abnormal_vocalization | 0.83105401 |
| 66 | MP0001727_abnormal_embryo_implantation | 0.82448971 |
| 67 | MP0003045_fibrosis | 0.75184733 |
| 68 | MP0003828_pulmonary_edema | 0.74777786 |
| 69 | MP0003879_abnormal_hair_cell | 0.70059324 |
| 70 | MP0002006_tumorigenesis | 0.69983470 |
| 71 | MP0003252_abnormal_bile_duct | 0.69101896 |
| 72 | MP0005381_digestive/alimentary_phenotyp | 0.65810435 |
| 73 | MP0005075_abnormal_melanosome_morpholog | 0.65306493 |
| 74 | MP0004130_abnormal_muscle_cell | 0.64828836 |
| 75 | MP0000920_abnormal_myelination | 0.64514282 |
| 76 | MP0003795_abnormal_bone_structure | 0.64317295 |
| 77 | MP0003075_altered_response_to | 0.63109579 |
| 78 | MP0003191_abnormal_cellular_cholesterol | 0.62417725 |
| 79 | MP0008873_increased_physiological_sensi | 0.59457178 |
| 80 | MP0003011_delayed_dark_adaptation | 0.58332266 |
| 81 | MP0008874_decreased_physiological_sensi | 0.57689159 |
| 82 | MP0003567_abnormal_fetal_cardiomyocyte | 0.57419275 |
| 83 | MP0008004_abnormal_stomach_pH | 0.56976320 |
| 84 | MP0002693_abnormal_pancreas_physiology | 0.56241812 |
| 85 | MP0002254_reproductive_system_inflammat | 0.55967597 |
| 86 | MP0000343_altered_response_to | 0.55037612 |
| 87 | MP0005390_skeleton_phenotype | 0.54808277 |
| 88 | MP0000249_abnormal_blood_vessel | 0.52499700 |
| 89 | MP0001853_heart_inflammation | 0.50681413 |
| 90 | MP0000750_abnormal_muscle_regeneration | 0.50324822 |
| 91 | MP0003172_abnormal_lysosome_physiology | 0.48590255 |
| 92 | MP0001905_abnormal_dopamine_level | 0.47160183 |
| 93 | MP0005377_hearing/vestibular/ear_phenot | 0.47113252 |
| 94 | MP0003878_abnormal_ear_physiology | 0.47113252 |
| 95 | MP0002019_abnormal_tumor_incidence | 0.47050576 |
| 96 | MP0002127_abnormal_cardiovascular_syste | 0.45401851 |
| 97 | MP0005595_abnormal_vascular_smooth | 0.41515138 |
| 98 | MP0001765_abnormal_ion_homeostasis | 0.41413898 |
| 99 | MP0002928_abnormal_bile_duct | 0.39744306 |
| 100 | MP0001919_abnormal_reproductive_system | 0.37835413 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chronic otitis media (HP:0000389) | 8.63048355 |
| 2 | Nasal polyposis (HP:0100582) | 7.87769060 |
| 3 | Abnormality of the nasal mucosa (HP:0000433) | 6.59407958 |
| 4 | Recurrent abscess formation (HP:0002722) | 5.93918795 |
| 5 | Recurrent bronchitis (HP:0002837) | 5.68139736 |
| 6 | Chronic sinusitis (HP:0011109) | 5.60731445 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 5.48288623 |
| 8 | Eczematoid dermatitis (HP:0000976) | 5.15984418 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.05810051 |
| 10 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.91595995 |
| 11 | Abnormality of macrophages (HP:0004311) | 4.77182748 |
| 12 | T lymphocytopenia (HP:0005403) | 4.72118510 |
| 13 | Abnormality of T cell number (HP:0011839) | 4.60027556 |
| 14 | Myositis (HP:0100614) | 4.55397611 |
| 15 | Pustule (HP:0200039) | 4.36843805 |
| 16 | Orchitis (HP:0100796) | 3.75932888 |
| 17 | Encephalitis (HP:0002383) | 3.69810743 |
| 18 | Bronchitis (HP:0012387) | 3.52976748 |
| 19 | Retrobulbar optic neuritis (HP:0100654) | 3.50558223 |
| 20 | Optic neuritis (HP:0100653) | 3.50558223 |
| 21 | Recurrent skin infections (HP:0001581) | 3.48442428 |
| 22 | Stomatitis (HP:0010280) | 3.48224212 |
| 23 | Hemiplegia (HP:0002301) | 3.47220016 |
| 24 | Abnormality of T cells (HP:0002843) | 3.45793407 |
| 25 | Recurrent fungal infections (HP:0002841) | 3.42940262 |
| 26 | Leukocytosis (HP:0001974) | 3.41623714 |
| 27 | Gingivitis (HP:0000230) | 3.40959809 |
| 28 | Increased IgM level (HP:0003496) | 3.36125717 |
| 29 | Meningitis (HP:0001287) | 3.35437466 |
| 30 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.24448842 |
| 31 | Hypothermia (HP:0002045) | 3.15447229 |
| 32 | Increased IgE level (HP:0003212) | 3.15021961 |
| 33 | Eosinophilia (HP:0001880) | 3.13216530 |
| 34 | Hypoproteinemia (HP:0003075) | 3.12577589 |
| 35 | Emphysema (HP:0002097) | 3.01649216 |
| 36 | Spontaneous hematomas (HP:0007420) | 2.98917313 |
| 37 | Global brain atrophy (HP:0002283) | 2.95621781 |
| 38 | Agammaglobulinemia (HP:0004432) | 2.93114946 |
| 39 | Gastrointestinal infarctions (HP:0005244) | 2.92850245 |
| 40 | Autoimmune hemolytic anemia (HP:0001890) | 2.92326647 |
| 41 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.92183543 |
| 42 | Granulocytopenia (HP:0001913) | 2.92118701 |
| 43 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.89694717 |
| 44 | Recurrent cutaneous fungal infections (HP:0011370) | 2.89694717 |
| 45 | Obstructive lung disease (HP:0006536) | 2.88741366 |
| 46 | Chronic obstructive pulmonary disease (HP:0006510) | 2.88741366 |
| 47 | Keratoconjunctivitis (HP:0001096) | 2.80998476 |
| 48 | Periodontitis (HP:0000704) | 2.75571713 |
| 49 | Abnormality of eosinophils (HP:0001879) | 2.75558550 |
| 50 | Vasculitis (HP:0002633) | 2.73758130 |
| 51 | Joint swelling (HP:0001386) | 2.73707960 |
| 52 | Mediastinal lymphadenopathy (HP:0100721) | 2.69812036 |
| 53 | Keratoconjunctivitis sicca (HP:0001097) | 2.67916190 |
| 54 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.65658360 |
| 55 | Recurrent viral infections (HP:0004429) | 2.63319198 |
| 56 | Hypergammaglobulinemia (HP:0010702) | 2.62378285 |
| 57 | Chronic diarrhea (HP:0002028) | 2.52091870 |
| 58 | Lymphopenia (HP:0001888) | 2.51459450 |
| 59 | Severe combined immunodeficiency (HP:0004430) | 2.51351060 |
| 60 | Panhypogammaglobulinemia (HP:0003139) | 2.50917249 |
| 61 | Metaphyseal cupping (HP:0003021) | 2.47017365 |
| 62 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.44237627 |
| 63 | Urticaria (HP:0001025) | 2.41794144 |
| 64 | Prolonged bleeding time (HP:0003010) | 2.39603087 |
| 65 | Hypochromic anemia (HP:0001931) | 2.36478354 |
| 66 | Constricted visual fields (HP:0001133) | 2.34443887 |
| 67 | Bronchiectasis (HP:0002110) | 2.30552709 |
| 68 | Alveolar cell carcinoma (HP:0006519) | 2.29372293 |
| 69 | Hypochromic microcytic anemia (HP:0004840) | 2.25658790 |
| 70 | Inflammation of the large intestine (HP:0002037) | 2.23366391 |
| 71 | Chest pain (HP:0100749) | 2.16972073 |
| 72 | Pulmonary embolism (HP:0002204) | 2.14611828 |
| 73 | Recurrent otitis media (HP:0000403) | 2.12052529 |
| 74 | Gastrointestinal inflammation (HP:0004386) | 2.11146424 |
| 75 | Autoimmune thrombocytopenia (HP:0001973) | 2.11092301 |
| 76 | Microcytic anemia (HP:0001935) | 2.10995347 |
| 77 | Anorexia (HP:0002039) | 2.09420131 |
| 78 | Increased serum ferritin (HP:0003281) | 2.08638499 |
| 79 | Premature loss of primary teeth (HP:0006323) | 2.07928574 |
| 80 | Gingival bleeding (HP:0000225) | 2.07889534 |
| 81 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.07106803 |
| 82 | Ectopia lentis (HP:0001083) | 2.04840879 |
| 83 | Pulmonary infiltrates (HP:0002113) | 2.03265749 |
| 84 | Hemoptysis (HP:0002105) | 2.03259514 |
| 85 | Abnormality of T cell physiology (HP:0011840) | 2.02791506 |
| 86 | Purpura (HP:0000979) | 2.02682191 |
| 87 | Thick nail (HP:0001805) | 2.02215290 |
| 88 | Diplopia (HP:0000651) | 2.01723393 |
| 89 | Abnormality of binocular vision (HP:0011514) | 2.01723393 |
| 90 | Acute hepatic failure (HP:0006554) | 2.01600969 |
| 91 | Papilledema (HP:0001085) | 1.98997432 |
| 92 | Epistaxis (HP:0000421) | 1.96713634 |
| 93 | Cellulitis (HP:0100658) | 1.95700731 |
| 94 | Skin ulcer (HP:0200042) | 1.94928596 |
| 95 | Combined immunodeficiency (HP:0005387) | 1.93328544 |
| 96 | IgG deficiency (HP:0004315) | 1.91309781 |
| 97 | Striae distensae (HP:0001065) | 1.87673120 |
| 98 | Attenuation of retinal blood vessels (HP:0007843) | 1.85289974 |
| 99 | IgM deficiency (HP:0002850) | 1.82482975 |
| 100 | Abnormality of iron homeostasis (HP:0011031) | 1.82386863 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K13 | 8.13472029 |
| 2 | MAP4K1 | 4.16894004 |
| 3 | TAOK3 | 3.31848578 |
| 4 | TLK1 | 3.16401653 |
| 5 | FES | 3.00903840 |
| 6 | TXK | 2.97266565 |
| 7 | TESK2 | 2.47897741 |
| 8 | RIPK4 | 2.34135906 |
| 9 | MAP3K14 | 2.31033869 |
| 10 | CSK | 2.26638890 |
| 11 | KDR | 2.25368840 |
| 12 | ZAP70 | 2.20664115 |
| 13 | BMPR2 | 2.01612821 |
| 14 | ARAF | 1.96829748 |
| 15 | TNK2 | 1.88499298 |
| 16 | BTK | 1.85695756 |
| 17 | TYK2 | 1.70968615 |
| 18 | GRK6 | 1.70946972 |
| 19 | ERN1 | 1.69899524 |
| 20 | SYK | 1.60524736 |
| 21 | MAP3K9 | 1.58091402 |
| 22 | ITK | 1.57479492 |
| 23 | HCK | 1.46518852 |
| 24 | BLK | 1.45570544 |
| 25 | MOS | 1.43506422 |
| 26 | TESK1 | 1.42380985 |
| 27 | LCK | 1.39636312 |
| 28 | KSR2 | 1.39375807 |
| 29 | FGR | 1.26446048 |
| 30 | MAP3K7 | 1.25047463 |
| 31 | IRAK4 | 1.14354654 |
| 32 | MAP2K3 | 1.14146437 |
| 33 | JAK1 | 1.12523114 |
| 34 | LYN | 1.09989951 |
| 35 | GRK7 | 1.08632931 |
| 36 | TEC | 1.06793456 |
| 37 | KIT | 1.06687586 |
| 38 | BRAF | 1.04729375 |
| 39 | PRPF4B | 1.04560087 |
| 40 | EPHB1 | 1.04205081 |
| 41 | PRKCH | 1.02756415 |
| 42 | IKBKB | 1.00484326 |
| 43 | PRKCQ | 0.98800767 |
| 44 | JAK3 | 0.92473761 |
| 45 | MAP3K11 | 0.90024023 |
| 46 | STK10 | 0.85022158 |
| 47 | IKBKE | 0.84959125 |
| 48 | PASK | 0.80367792 |
| 49 | TBK1 | 0.80129274 |
| 50 | PDK1 | 0.79859272 |
| 51 | CSF1R | 0.79025224 |
| 52 | MAP3K1 | 0.75368835 |
| 53 | ILK | 0.74737639 |
| 54 | MAP3K3 | 0.72707479 |
| 55 | MAP3K8 | 0.72300802 |
| 56 | FYN | 0.66361852 |
| 57 | STK38 | 0.66095253 |
| 58 | MAP3K12 | 0.64640740 |
| 59 | TGFBR2 | 0.62543053 |
| 60 | RAF1 | 0.60963815 |
| 61 | JAK2 | 0.60353991 |
| 62 | MAP2K6 | 0.57321492 |
| 63 | SIK3 | 0.55124007 |
| 64 | PTK6 | 0.52603206 |
| 65 | PIM1 | 0.51632573 |
| 66 | TAOK1 | 0.51569681 |
| 67 | PDPK1 | 0.51374589 |
| 68 | PTK2B | 0.51278031 |
| 69 | MARK3 | 0.50127985 |
| 70 | LIMK1 | 0.47040832 |
| 71 | LRRK2 | 0.44982401 |
| 72 | ADRBK2 | 0.40710073 |
| 73 | PRKD2 | 0.39937586 |
| 74 | CDK4 | 0.39549610 |
| 75 | PIK3CG | 0.37214113 |
| 76 | SIK2 | 0.37126864 |
| 77 | KSR1 | 0.36489319 |
| 78 | TYRO3 | 0.32875811 |
| 79 | INSR | 0.29829319 |
| 80 | CAMKK1 | 0.29104648 |
| 81 | ADRBK1 | 0.28086383 |
| 82 | MAPK12 | 0.28055111 |
| 83 | TAOK2 | 0.26041951 |
| 84 | CHUK | 0.22162732 |
| 85 | IGF1R | 0.21094932 |
| 86 | MYLK | 0.21051280 |
| 87 | MARK2 | 0.20806044 |
| 88 | ABL1 | 0.18938638 |
| 89 | YES1 | 0.18843327 |
| 90 | MAPK7 | 0.18770557 |
| 91 | MAPKAPK2 | 0.18107606 |
| 92 | CDC42BPA | 0.16613412 |
| 93 | TTN | 0.16598152 |
| 94 | PDGFRB | 0.16108609 |
| 95 | PRKAA2 | 0.15050230 |
| 96 | GRK5 | 0.14570285 |
| 97 | BCKDK | 0.14494069 |
| 98 | MAP2K2 | 0.13810427 |
| 99 | MAPK4 | 0.13028587 |
| 100 | SRC | 0.12496126 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 4.43448110 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.91481452 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.58733380 |
| 4 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.27760821 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 3.05698332 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.99103210 |
| 7 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.68952440 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.54180657 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.42071518 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.39577010 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.35999833 |
| 12 | Viral myocarditis_Homo sapiens_hsa05416 | 2.32840554 |
| 13 | Malaria_Homo sapiens_hsa05144 | 2.27850801 |
| 14 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.91393954 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.90008329 |
| 16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.88375702 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.79420502 |
| 18 | Measles_Homo sapiens_hsa05162 | 1.61628226 |
| 19 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.59145532 |
| 20 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.46377519 |
| 21 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.42643804 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.42470218 |
| 23 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.36745770 |
| 24 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.35984226 |
| 25 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.31222033 |
| 26 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.29860494 |
| 27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.29101386 |
| 28 | Tuberculosis_Homo sapiens_hsa05152 | 1.27666926 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.24225937 |
| 30 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.18468466 |
| 31 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.18284939 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.17571952 |
| 33 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.14700730 |
| 34 | Shigellosis_Homo sapiens_hsa05131 | 1.05212762 |
| 35 | Apoptosis_Homo sapiens_hsa04210 | 1.03324162 |
| 36 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.99836181 |
| 37 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.99287114 |
| 38 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.99264028 |
| 39 | Legionellosis_Homo sapiens_hsa05134 | 0.98656838 |
| 40 | Phagosome_Homo sapiens_hsa04145 | 0.95446078 |
| 41 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.93452461 |
| 42 | Pertussis_Homo sapiens_hsa05133 | 0.92323447 |
| 43 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.91783341 |
| 44 | Influenza A_Homo sapiens_hsa05164 | 0.91664145 |
| 45 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.90249430 |
| 46 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.89528558 |
| 47 | Platelet activation_Homo sapiens_hsa04611 | 0.85759423 |
| 48 | Asthma_Homo sapiens_hsa05310 | 0.84632533 |
| 49 | Hepatitis C_Homo sapiens_hsa05160 | 0.83182905 |
| 50 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.78530311 |
| 51 | Ribosome_Homo sapiens_hsa03010 | 0.76358468 |
| 52 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.75387380 |
| 53 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.73475995 |
| 54 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.66671663 |
| 55 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.66184978 |
| 56 | HTLV-I infection_Homo sapiens_hsa05166 | 0.64480629 |
| 57 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.62992265 |
| 58 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.62755894 |
| 59 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.62448136 |
| 60 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.60032380 |
| 61 | Salmonella infection_Homo sapiens_hsa05132 | 0.59877008 |
| 62 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.56424031 |
| 63 | Hepatitis B_Homo sapiens_hsa05161 | 0.56140289 |
| 64 | Olfactory transduction_Homo sapiens_hsa04740 | 0.54493871 |
| 65 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.54119703 |
| 66 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53788456 |
| 67 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.53702500 |
| 68 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.52826375 |
| 69 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.50905156 |
| 70 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.49869453 |
| 71 | Prion diseases_Homo sapiens_hsa05020 | 0.45728077 |
| 72 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.45384558 |
| 73 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.44161346 |
| 74 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.44014729 |
| 75 | Long-term potentiation_Homo sapiens_hsa04720 | 0.42876085 |
| 76 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.42020659 |
| 77 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.41896052 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41475156 |
| 79 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41405233 |
| 80 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.40979606 |
| 81 | Endocytosis_Homo sapiens_hsa04144 | 0.40335658 |
| 82 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39714413 |
| 83 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38442254 |
| 84 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.35858239 |
| 85 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35708583 |
| 86 | Colorectal cancer_Homo sapiens_hsa05210 | 0.34861917 |
| 87 | Lysosome_Homo sapiens_hsa04142 | 0.33840283 |
| 88 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32581661 |
| 89 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.32560599 |
| 90 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.32227851 |
| 91 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.29957817 |
| 92 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.28956640 |
| 93 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.28668446 |
| 94 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.28621484 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.27946502 |
| 96 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.27505417 |
| 97 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.27120434 |
| 98 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.26065297 |
| 99 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.21784135 |
| 100 | Amoebiasis_Homo sapiens_hsa05146 | 0.20018737 |

